Login / Signup

Drug survival in patients with psoriasis is associated with the availability of biologic medications.

G ShalomArnon D CohenI FeldhamerD ComaneshterT FreudL Pavlovsky
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
Different drug survival rates between ustekinumab and secukinumab are determined by the treatment line and calendar year, reflecting the availability of biologic medications, and not only by the biologic attributes of each medication.
Keyphrases
  • rheumatoid arthritis
  • adverse drug
  • ankylosing spondylitis
  • free survival
  • disease activity
  • healthcare
  • emergency department
  • drug induced
  • smoking cessation